The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: A matched case-case-control analysis

Tzach Aviv, Tsillia Lazarovitch, David Katz, Ronit Zaidenstein, Mor Dadon, Chen Daniel, Ruthy Tal-Jasper, Keith S. Kaye, Dror Marchaim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

A case-case-control investigation (N = 255 patients) explored the epidemiology of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Recent exposure to carbapenems and a rapidly fatal condition should prompt practitioners to shorten delays in initiating appropriate therapy, which can adversely impact CRPA outcomes, as opposed to the isolated impact of the carbapenem resistance determinant.

Original languageEnglish
Pages (from-to)1262-1265
Number of pages4
JournalInfection Control and Hospital Epidemiology
Volume39
Issue number10
DOIs
StatePublished - 1 Oct 2018

Fingerprint

Dive into the research topics of 'The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: A matched case-case-control analysis'. Together they form a unique fingerprint.

Cite this